European Pharmaceutical Review
JULY 25, 2023
percent during the forecast period from 2023 to 2032 is predicted. The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines. A compound annual growth rate (CAGR) growth of 5.9
STAT
OCTOBER 10, 2023
At least 56 drug firms based in Massachusetts (or with operations here) have made layoffs or closed in 2023 through September, according to Dan Gold, president of Fairway Consulting Group, a life sciences recruiting firm. But the drumbeat of layoffs in 2022 has only grown louder this year. He estimated U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 26, 2022
Astellas has won a reprieve in its attempt to stop Pfizer’s generic medicines unit Hospira launching a copycat version of its pharmacologic stress agent Lexiscan in the US – but only for a couple of weeks. ” Hospira isn’t the only generics company trying to bring a version of regadenoson to the US market.
The Checkup by Singlecare
JULY 17, 2023
Zoloft is a brand-name medication with a generic option available called sertraline. Sertraline is the second most commonly prescribed antidepressant of 2023 so far (second to generic Lexapro), according to SingleCare script data. With a generic option of Zoloft available, sertraline is often a more affordable option for people.
The Checkup by Singlecare
OCTOBER 12, 2023
This is because generic medicines are much less expensive than their brand-name counterparts, even though they work just as well. What are the differences between brand name and generic Abilify? Aripiprazole was approved by the FDA in 2015. Aripiprazole is widely available at pharmacies across the U.S.
The Checkup by Singlecare
SEPTEMBER 18, 2023
It’s usually dispensed in pharmacies as a generic medicine, but healthcare providers commonly refer to it by brand names Flexeril (immediate-release tablets), Fexmid (immediate-release tablets), or Amrix (extended-release capsules). Cyclobenzaprine is a prescription muscle relaxant that is approved by the U.S. as a brand-name drug.
European Pharmaceutical Review
JANUARY 30, 2023
In its first meeting of 2023, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended four new medicines for approval, providing positive opinions for two type 2 diabetes drugs.
Expert insights. Personalized for you.
97 
Let's personalize your content